Table 1 Comparison of baseline characteristics between two groups of patients
Total | RTW group | Non-RTW group | P value | |
|---|---|---|---|---|
(n = 171) | (n = 119) | (n = 52) | ||
Demographic characteristics | ||||
Age, years, mean ± SD | 41.9 ± 9.6 | 40.9 ± 9.8 | 44.3 ± 8.9 | 0.033 |
20–29, n (%) | 23 (13.4) | 20 (16.8) | 3 (5.8) | 0.052 |
30–39, n (%) | 39 (22.8) | 29 (24.4) | 10 (19.2) | 0.461 |
40–49, n (%) | 68 (39.8) | 43 (36.1) | 25 (48.1) | 0.142 |
50–59, n (%) | 41 (24.0) | 27 (22.7) | 14 (26.9) | 0.551 |
< 40 years, n (%) | 62 (36.3) | 49 (41.2) | 13 (25.0) | 0.043 |
≥ 40 years, n (%) | 109 (63.7) | 70 (58.8) | 39 (75.0) | 0.043 |
Gender, (male/female) | 170/1 | 118/0 | 51/1 | 0.131 |
Body mass index, (kg/m2) (mean ± SD) | 23.5 ± 3.2 | 23.5 ± 3.4 | 23.7 ± 2.7 | 0.636 |
Married, n (%) | 160 (93.6) | 108 (90.8) | 51 (98.1) | 0.119 |
Having children, n (%) | 150 (87.7) | 101 (84.9) | 49 (94.2) | 0.099 |
College education, n (%) | 12 (7.0) | 10 (8.4) | 2 (3.8) | 0.283 |
Occupation | ||||
Mental worker, n (%) | 41 (30.0) | 39 (32.8) | 2 (3.8) | 0.002 |
Manual worker, n (%) | 82 (48.0) | 52 (43.7) | 30 (57.7) | 0.092 |
Farmer, n (%) | 11 (6.4) | 6 (5.0) | 5 (9.6) | 0.262 |
Self-employed, n (%) | 29 (17.0) | 18 (15.1) | 11 (21.2) | 0.334 |
Other, n (%) | 8 (4.6) | 4 (3.4) | 4 (7.7) | 0.217 |
Hometown region | ||||
Central, n (%) | 26 (15.2) | 18 (15.1) | 8 (15.4) | 0.965 |
East, n (%) | 124 (72.5) | 89 (74.8) | 35 (67.3) | 0.313 |
West, n (%) | 21 (12.3) | 12 (10.1) | 9 (17.3) | 0.186 |
Cardiovascular risk factors | ||||
Smoking history, n (%) | 141 (82.5) | 99 (83.2) | 42 (80.8) | 0.701 |
Hypertension, n (%) | 12 (7.0) | 8 (6.7) | 4 (7.7) | 0.819 |
Diabetes mellitus, n (%) | 12 (7.0) | 9 (7.6) | 3 (5.8) | 0.673 |
Hyperlipidaemia, n (%) | 15 (8.8) | 10 (8.4) | 5 (9.6) | 0.797 |
Cause of AICLI | ||||
TAO, n (%) | 159 (93.0) | 112 (94.1) | 47 (90.4) | 0.379 |
Other, n (%) | 12 (7.0) | 7 (5.9) | 5 (9.6) | 0.379 |
Medication history | ||||
Antiplatelet drugs, n (%) | 104 (60.8) | 77 (70.6) | 27 (51.9) | 0.115 |
Vasodilator, n (%) | 39 (22.8) | 19 (16.0) | 13 (25.0) | 0.164 |
Warfarin/Rivaroxaban, n (%) | 18 (10.5) | 11 (9.2) | 7 (13.5) | 0.408 |
Anti-infective treatment, n (%) | 5 (2.9) | 3 (2.5) | 2 (3.8) | 0.636 |
Surgical history | ||||
Bypass, n (%) | 6 (3.5) | 4 (3.4) | 2 (3.8) | 0.874 |
Endarterectomy, n (%) | 1 (0.6) | 0 (0.0) | 1 (1.9) | 0.129 |
Stent grafting, n (%) | 8 (4.7) | 4 (3.4) | 4 (7.7) | 0.217 |
Balloon angioplasty, n (%) | 25 (14.6) | 18 (10.5) | 7 (13.5) | 0.777 |
Thrombolysis, n (%) | 26 (15.2) | 17 (9.9) | 9 (17.3) | 0.613 |
Thrombectomy, n (%) | 12 (7.0) | 8 (4.7) | 4 (7.7) | 0.819 |
Toe amputation, n (%) | 19 (11.1) | 13 (10.9) | 6 (11.5) | 0.906 |
Blood examination, n (%) | ||||
Fibrinogen, mg/dL, (median, IQR) | 321.5 (257–408) | 307 (244–388) | 354 (292–477) | < 0.001 |
CRP, mg/L, (median, IQR) | 5.4 (1.8–14.8) | 4.5 (1.55–11.65) | 8.2 (2.3–18.7) | 0.022 |
Glucose, mmol/L, (median, IQR) | 4.7 (4.4–5.2) | 4.7 (4.4–5.1) | 4.8 (4.6–5.3) | 0.915 |
GHb, %, (median, IQR) | 5.4 (5.2–5.7) | 5.45 (5.2–5.7) | 5.4 (5.25–5.60) | 0.359 |
Creatinine, μmol/L, (median, IQR) | 71.5 (64–82) | 72 (65–82) | 71 (63–82) | 0.600 |
GFR, mL/min, (median, IQR) | 107 (99–119) | 107 (97–117) | 109 (101.5–120) | 0.222 |
ESR, mm/h, (median, IQR) | 14 (7–30) | 14.5 (7–32) | 13 (6–26) | 0.453 |